Teprotumumab and Hyperglycemia Guidelines to Monitor for Hyperglycemia in Teprotumumab.

[1]  Terry J. Smith,et al.  Teprotumumab for the Treatment of Active Thyroid Eye Disease. , 2020, The New England journal of medicine.

[2]  Terry J. Smith,et al.  Teprotumumab for Thyroid‐Associated Ophthalmopathy , 2017, The New England journal of medicine.

[3]  J. Goldman,et al.  Hyperglycemia Associated With Targeted Oncologic Treatment: Mechanisms and Management. , 2016, The oncologist.

[4]  A. Bader,et al.  Early Identification of Individuals with Poorly Controlled Diabetes Undergoing Elective Surgery: Improving A1C Testing in the Preoperative Period. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[5]  K. Dhatariya,et al.  NHS Diabetes guideline for the perioperative management of the adult patient with diabetes * , 2012, Diabetic medicine : a journal of the British Diabetic Association.